Table 1. Summary of oesophageal cancer patients.

Study number	Age at diagnosis (years)	Gender	Ethnic origin	Tumour type	Chemotherapy	Drug regime	Further treatment	Tumour regression grade
T001	66	Male	White	Adenocarcinoma	Neoadjuvant	CF	Surgery	TRG5
T002	58	Male	White	Adenocarcinoma	Neoadjuvant	CF	Surgery	TRG5
T003	62	Male	White	Adenocarcinoma	Neoadjuvant	CF	Surgery	TRG5
T004	62	Male	White	Adenocarcinoma	Neoadjuvant	CF	Surgery	TRG4
T005	57	Male	White	Adenocarcinoma	Neoadjuvant	ECF	Surgery	TRG5
T006	58	Male	White	Adenocarcinoma	Neoadjuvant	CF	Surgery	TRG4
T007	51	Male	White	Adenocarcinoma	Neoadjuvant	CF	Surgery	TRG4
T008	58	Male	White	Adenocarcinoma	Chemoradiation	CF	Stent	N/A
T009	72	Male	White	Squamous cell carcinoma	Palliative	ECF	Stent	N/A
T010	68	Male	White	Poorly differentiated carcinoma	Palliative	ECF	None	N/A
T011	49	Male	White	Poorly differentiated carcinoma	Palliative	ECF	None	N/A
T012	52	Male	White	Adenocarcinoma	Palliative	ECF	Stent/radiation	N/A
T013	60	Male	White	Dysplasia	None	None	None	N/A
T014	45	Female	White	Adenocarcinoma	Palliative	ECF	Radiation	N/A
T015	60	Male	White	Adenocarcinoma	Neoadjuvant	CF	Surgery& radiation	TRG5
T016	54	Male	White	Adenocarcinoma	Neoadjuvant	ECF	Surgery	TRG5
T017	68	Male	White	Adenocarcinoma	None	None	Radiation	N/A
T018	64	Male	White	Adenocarcinoma	None	None	None	N/A
T019	51	Male	White	Adenocarcinoma	Palliative	ECF	None	N/A
T020	74	Female	White	Adenocarcinoma	Palliative	ECaF	None	N/A
T021	49	Male	White	Adenocarcinoma	Neoadjuvant	CF	Surgery	TRG4
T022	71	Female	White	Adenocarcinoma	Palliative	MF	None	N/A
T023	58	Female	White	Adenocarcinoma	Neoadjuvant	CF	Surgery	TRG5
T024	64	Male	White	Adenocarcinoma	Chemoradiation	F	Radiation	N/A

Abbreviations: C=cisplatin; Ca=carboplatin; E=epirubicin; F=5-fluorouracil; M=mitomycin c.